In ANPs plus RT group, CD4+ T/Tregs and CD8+ T/Tregs ratio were notably increased compared to control or RT alone, implying that can enhanced regional and systematic anti-tumor ability and improved tumor immune environment [164]. The gene discussed is CD8A; the disease is neoplasm.